Sr9011 The dominant search intent for "SR9009 peptide" appears to be informational, focusing on understanding what SR9009 is, its mechanism of action, and its potential effects, particularly in the context of research and its purported benefits, while also acknowledging its status as a research chemicalHuma Peptide SR-9009.
Tier 1 Entities & Phrases:
* SR9009
* Stenabolic
* REV-ERB agonist
* metabolic diseases
* fatty acid oxidation
* glucose metabolism
* weight loss
* research drug
Tier 2 Entities & Phrases:
* synthetic compound
* modulator of Toll-like receptor (TLR) signaling pathways
* agonist of Rev-ErbA
* regulates lipid metabolism
* circadian locomotor activity
* NR1D1 synthesis
* obesity
* diabetes
* athletic performance
* gene expression
* inflammation
Tier 3 Entities & Phrases:
* Bisphenol A
* testosterone production in Leydig cells
* estrogen receptor β agonist
* Peptide
* Recombinant/Purified Protein
* Nonsteroidal compound
* Chemotherapeutic Effect
* cancer research
SR9009, also widely recognized by its common name Stenabolic, is a synthetic compound that has garnered significant attention within research circlesSR9009 | 1379686-30-2 | FS159307. As a potent REV-ERB agonist, its primary mechanism of action involves influencing the body's internal clock and metabolic processes. This research drug is explored for its potential to modulate numerous physiological pathways, including fatty acid oxidation and glucose metabolism, which are central to energy balance and weight loss. While research into SR9009 is ongoing, its classification as a synthetic REV-ERB agonist highlights its specific interaction with the REV-ERBα and REV-ERBβ nuclear receptors.SR9009 is a REV-ERBα/β agonistwith IC50s of 670 nM and 800 nM for REV-ERBα and REV-ERBβ, respectively. For research use only. We do not sell to patients.
SR9009 functions as a small molecule agonist designed to activate the REV-ERB (Nuclear Receptor subfamily 1, group D, member 1 and 2) proteins. These proteins play a crucial role in regulating circadian rhythms, lipid metabolism, and glucose homeostasis. By binding to and activating REV-ERB receptors, SR9009 essentially mimics the action of natural heme molecules, which are endogenous ligands for these receptorsStenabolicis used for weight loss, diabetes, to improve athletic performance, and for other uses, but there is no good scientific evidence to support its use.. This activation leads to increased repression of genes regulated by REV-ERB, thereby influencing a cascade of downstream effects related to energy expenditure and metabolism. Studies suggest that SR9009 can alter circadian locomotor activity and core clock hypothalamic gene expression in mice, underscoring its influence on the body's internal timing mechanisms.
The research surrounding SR9009 has explored a variety of potential effects, primarily centered on metabolic health and performance. Its ability to enhance fatty acid oxidation and glucose metabolism has led to investigations into its role in managing metabolic diseases such as obesity and diabetesBisphenol A attenuates testosterone production in Leydig cells via the .... By promoting the conversion of stored fat into energy and improving glucose utilization, SR9009 is studied for its potential to induce weight loss in diet-induced obese mice.
Beyond metabolic regulation, SR9009 has also been examined for its impact on inflammation and cellular processes. Some research indicates that it can attenuate inflammation-related markers and may possess protective effects in certain biological systems. Furthermore, its influence on circadian rhythms has led to its exploration in contexts related to energy balance and activity patterns.
It is crucial to emphasize that SR9009 is classified as a research drug and is not approved for human consumptionREV-ERBα Agonist SR9009 Promotes a Negative Energy .... Its availability is typically limited to laboratory and research settings.Induces weight loss in diet-induced obese mice. Brain penetrant. Compound Libraries for SR 9009. SR 9009 is also offered as part of the Tocriscreen 2.0 Max. The scientific community utilizes SR9009 to further understand the complex roles of REV-ERB receptors in physiology and pathology.Stenabolicis used for weight loss, diabetes, to improve athletic performance, and for other uses, but there is no good scientific evidence to support its use. While anecdotal reports and discussions exist regarding its use for purposes like athletic performance enhancement, these applications lack robust scientific validation and carry inherent risks due to the compound's status as an unapproved research chemical.SR9009 | REV-ERB Agonist | MedChemExpress
While SR9009 is sometimes mistakenly associated with other classes of compounds, its identity as a REV-ERB agonist is key. Unlike selective androgen receptor modulators (SARMs), SR9009 does not directly target androgen receptors. Its mechanism is specifically linked to the nuclear receptor subfamily 1, group D. Other related compounds, such as SR9011, also act as REV-ERB agonists but may exhibit different potencies or pharmacokinetic profiles.作者：ZN Huang·2024·被引用次数：13—SR9009, as an agonist of NR1D1 synthesis, is non-toxic and shows extensive protective effects in vivo, such as regulating lipid metabolism. ... In ...
In summary, SR9009 (Stenabolic) is a significant synthetic compound that acts as a REV-ERB agonist. Its primary research focus lies in its profound effects on fatty acid oxidation, glucose metabolism, and circadian regulation, making it a subject of interest for understanding and potentially managing metabolic diseases and influencing energy balance. However, it remains a research drug with no approved therapeutic uses in humans.
Join the newsletter to receive news, updates, new products and freebies in your inbox.